SCHEMBL24309882

SCHEMBL24309882

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 1/20 0.37
▸ PDE2A O00408 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ ADRA2A P08913 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ ITK Q08881 1/20 0.34
▸ IGF1R P08069 1/20 0.34
▸ HRH4 Q9H3N8 2/20 0.33
▸ TTK P33981 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ MAP3K7 O43318 2/20 0.33
▸ TNK2 Q07912 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAP2K1 Q02750 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ TYK2 P29597 1/20 0.33
▸ STAT3 P40763 1/20 0.33
▸ JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309719 0.94 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24310690 0.92 PDE2A (0.34) PDE2APDE10AADRA2AADRA2BADRA2C
SCHEMBL24309392 0.89 BRD4 (0.37) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24310424 0.89 PDE2A (0.41) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24310428 0.89 MAP4K1 (0.38) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24310158 0.88 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24309386 0.87 JAK2 (0.37) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24310171 0.87 CTSC (0.36) MAP4K1PDE2APDE10AITKIGF1R
SCHEMBL24309378 0.85 IGF1R (0.30) IGF1R
SCHEMBL29567333 0.83 RAD52 (0.39) MAP4K1PDE2APDE10AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback